Bank of America’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-102
| Closed | -$67 | – | 7436 |
|
|
2024
Q4 | $67 | Sell |
102
-4
| -4% | -$3 | ﹤0.01% | 6891 |
|
|
2024
Q3 | $40 | Buy |
106
+56
| +112% | +$21 | ﹤0.01% | 6940 |
|
|
2024
Q2 | $64 | Buy |
+50
| New | +$64 | ﹤0.01% | 6899 |
|
|
2022
Q2 | – | Sell |
-349,900
| Closed | -$3.39M | – | 7468 |
|
|
2022
Q1 | $3.39M | Hold |
349,900
| – | – | ﹤0.01% | 3493 |
|
|
2021
Q4 | $3.38M | Buy |
349,900
+100,000
| +40% | +$966K | ﹤0.01% | 3458 |
|
|
2021
Q3 | $2.42M | Buy |
+249,900
| New | +$2.42M | ﹤0.01% | 3640 |
|